The Business Research Company’s report on the Molecular Biology Enzymes & Kits & Reagents Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the molecular biology enzymes & kits & reagents market in recent years?
The rising prevalence of infectious diseases is expected to propel the growth of the molecular biology enzymes, kits, and reagents market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, fungi, parasites, and others. The molecular biology enzymes, kits, and reagents help isolate and characterize infectious organisms to control and treat patients. For instance, in November 2023, according to the New South Wales Ministry of Health, a Australia-based government organization, emergency department visits assigned a diagnosis of chickenpox infection increased significantly from 549 in 2022 to 687 in 2023, reflecting a rise of 25% in cases over the one-year period. Therefore, the increase in the incidence of infectious diseases is driving the growth of the molecular biology enzymes, kits, and reagents market.
Access Your Free Sample of the Global Molecular Biology Enzymes & Kits & Reagents Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8346&type=smp
What is the projected market size of the molecular biology enzymes & kits & reagents industry, and how is it expected to grow?
The molecular biology enzymes & kits & reagents market size has grown rapidly in recent years. It will grow from $20.87 billion in 2024 to $24 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to genomic research advancements, biotechnology industry growth, diagnostic and therapeutic advancements, focus on genomic sequencing, advancements in cloning techniques.
The molecular biology enzymes & kits & reagents market size is expected to see rapid growth in the next few years. It will grow to $44.3 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to automation and high-throughput solutions, regenerative medicine focus, tissue engineering applications, RNA interference techniques. Major trends in the forecast period include biotechnology and life sciences growth, PCR-based technologies, proteomics advancements, drug discovery applications, stem cell research expansion, collaborations and research funding.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8346&type=smp
Who are the key players driving competition in the molecular biology enzymes & kits & reagents market?
Major companies operating in the molecular biology enzymes & kits & reagents market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Promega Corporation, New England Biolabs Inc., Illumina Inc., Takara Bio USA Holdings Inc., QIAGEN, Agilent Technologies Inc., F Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., LGC Group, Jena Bioscience GmbH, Molecular Biology Resources Inc., Integrated DNA Technologies Inc., Randox Laboratories, ADS Biotec Inc., Goldsite Diagnostics Inc., GE Healthcare, Lucigen Corporation, Bio Basic Inc., Bioo Scientific Corporation, Bioline, Biotechrabbit GmbH, BioWORLD, Epicentre, Hamilton Company, Omega Bio-tek, Sigma-Aldrich, Zymo Research, Abcam plc.
What key trends are expected to drive the molded interconnect device (mid) market during the forecast period?
Technological innovation is a key trend gaining popularity in the molecular biology enzymes, kits, and reagents market. Major market players are creating innovative technologies to identify diseases faster by removing bottlenecks in the process. Such innovations enable key players to gain a competitive edge in the market. For instance, in June 2022, Altona Diagnostics, a Germany-based healthcare and diagnostics company, launched RealStar Zoonotic Orthopoxvirus PCR Kit 1.0, a diagnostic tool designed for the specific detection of zoonotic orthopoxviruses, which are viruses that can be transmitted from animals to humans. This kit employs real-time polymerase chain reaction (PCR) technology to amplify and detect specific DNA sequences associated with orthopoxviruses, enabling rapid and accurate identification in clinical and research settings. It is particularly relevant for monitoring zoonotic diseases and aiding in public health responses. The kit includes all necessary reagents and is suitable for use with various sample types, making it a valuable asset for laboratories working with infectious diseases.
Which key geographies are driving the growth of the molecular biology enzymes & kits & reagents market?
North America was the largest region in the molecular biology enzymes, kits, and reagents market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular biology enzymes & kits & reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the key segments driving growth in the molecular biology enzymes & kits & reagents market?
The molecular biology enzymes & kits & reagents market covered in this report is segmented –
1) By Product: Kits And Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes
2) By Application: Sequencing, Cloning, PCR, Epigenetics, Restriction Digestion, Other Applications
3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology companies, Hospitals And Diagnostic Centers, Other End Users
Subsegments:
1) By Kits And Reagents: DNA Extraction Kits, RNA Extraction Kits, PCR Kits, Sequencing Kits, Cloning Kits
2) By Enzymes: DNA Polymerases, RNA Polymerases
3) By Polymerases: Taq Polymerase, High-Fidelity Polymerases, Reverse Transcriptases
4) By Ligases: DNA Ligases, RNA Ligases
5) By Restriction Endonucleases: Type II Restriction Enzymes, Type I And III Restriction Enzyme
6) By Reverse Transcriptases: M-MuLV Reverse Transcriptase, AMV Reverse Transcriptase
7) By Other Enzymes: Exonucleases, Nucleases, Proteases
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8346
How is the molecular biology enzymes & kits & reagents market defined, and what are its core characteristics?
The molecular biology enzymes, kits, and reagents refer to the identification and isolation of DNA or RNA fragments from a complex mixture of nucleic acids for drug discovery and development studies and clinical investigations of candidate drug molecules. Pharmaceutical companies use these in cloning, analysis, and sequencing of RNA, DNA, and proteins, DNA isolation, and protein analysis.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
